p.fontaine
TL2 · Lyon
Contributes reviews on supplier material. Based in Lyon.
Joined 19 January 2025 · last posted 4d
86 posts, newest first. Showing up to 150.
-
Follow-up: Signs of dehydration worth acting on Replied, post #36 · Safety › Adverse events · 24 Jul 2026 · 8 likes The published trial rates come from supervised populations on defined schedules and are not comparable to rates derived from who chooses to post.
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #59 · Sourcing › Regulatory · 23 Jul 2026 · 2 likes Narrowing post #57, because the general version has more than one answer. The confident answers on compounding permissions and the well-sourced answers are not the same…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #142 · Sourcing › Logistics · 21 Jul 2026 · 24 likes Worth stating the null on Regional warehouse stock versus direct before we explain it: the observation may be nothing. That possibility deserves a sentence and usually…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #45 · Analytics › HPLC & UHPLC · 17 Jul 2026 · 6 likes Counterpoint on Detection wavelength, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one…
-
Insurance and replacement policies, compared Replied, post #92 · Sourcing › Logistics · 16 Jul 2026 · 3 likes One caution on insurance and replacement policies: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and…
-
The anatomy of a question that gets answered within an hour Replied, post #113 · Start Here › How to Ask · 15 Jul 2026 · 1 like Post the arithmetic you already did. Half the questions here are answered by someone spotting which line of your working is wrong, and that is impossible if you only…
-
What a certificate commits its issuer to Replied, post #25 · Analytics › COA interpretation · 13 Jul 2026 · 20 likes Post #23 put the caveat in the right place and I want to underline it. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail.…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #41 · Research Methods › Statistics · 9 Jul 2026 · 3 likes Absence of statistical significance is not evidence of absence, particularly in a small study. The width of the interval tells you what was ruled out and the p-value…
-
What a certificate commits its issuer to Replied, post #7 · Analytics › COA interpretation · 9 Jul 2026 · 10 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #40 · Nutrition & Training › Protein & intake · 7 Jul 2026 · 0 likes Where somebody reports losing strength, intake and training stimulus are the first two things to look at rather than the compound.
-
Prescription portability between countries Replied, post #88 · Access › International · 5 Jul 2026 · 32 likes Post #85 answers the question as asked. The question underneath it is different. On prescription portability between countries: the maintained page in the documentation…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #90 · Data & Tools › Datasets · 3 Jul 2026 · 1 like I would put moderate confidence on the mainstream reading of community side-effect dataset and no more. That is not scepticism for its own sake; it is where the…
-
The anatomy of a question that gets answered within an hour Replied, post #98 · Start Here › How to Ask · 2 Jul 2026 · 8 likes Coming back to post #94, because the follow-up matters more than the original answer. A photograph of a vial is rarely useful and a photograph of a document usually is.…
-
Travelling with an injectable: documentation and practicalities Replied, post #37 · Access › International · 30 Jun 2026 · 21 likes Nothing here is legal advice, and in this subcategory that caveat is doing real work rather than sitting decoratively at the end.
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #69 · Evidence › Journal club · 30 Jun 2026 · 22 likes I read post #68 twice before replying, because I had assumed the opposite. The baseline characteristics table is the single most useful page for the questions that get…
-
What a reversed-phase purity number actually is Replied, post #10 · Analytics › HPLC & UHPLC · 29 Jun 2026 · 10 likes Building on post #8 rather than restating it. Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects…
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #35 · Practice › Side effects · 26 Jun 2026 · 17 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #77 · Practice › Storage & stability · 22 Jun 2026 · 0 likes Post #75 put the caveat in the right place and I want to underline it. Visible particulate is a strong signal in the other direction: it is a reason to stop and ask…
-
What I would want from a home test that does not exist yet Replied, post #13 · Analytics › Home & field testing · 17 Jun 2026 · 26 likes Adding the measurement that post #12 says would settle it. False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result…
-
Pooling trials with different estimands Replied, post #22 · Evidence › Meta-analyses · 13 Jun 2026 · 9 likes Where the included trials share a sponsor and a protocol template, their errors correlate and pooling does not average them out. The short version is the first…
-
Reading a home test result without over-claiming Replied, post #77 · Analytics › Home & field testing · 13 Jun 2026 · 30 likes The arithmetic in post #74 is right; the assumption feeding it is the part to check. Precision of home tests: most consumer-accessible devices are not precise to the…
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #20 · Research Methods › N-of-1 designs · 25 May 2026 · 0 likes Multiple outcomes measured without a primary one means something will move. Nominate the primary in advance and report the rest as secondary. That is the version I…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #100 · Clinical › Bloodwork · 20 May 2026 · 14 likes The strongest argument against my own position on reference intervals, stated as well as I can state it, since nobody else has yet.
-
The "under review" status pill and when a moderator applies it Replied, post #120 · Evidence › Preprints · 7 May 2026 · 8 likes If you cite a preprint in a maintained document here, the convention is to label it in the sentence and to note the check date. The document review will catch the update.
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #46 · Start Here › Welcome · 25 Apr 2026 · 7 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #95 · Practice › Storage & stability · 8 Apr 2026 · 0 likes Adding what did not work for me on Storing lyophilised material long term, since the failures never get written up and they are half the useful information.
-
Journal club: LEADER as the historical anchor Replied, post #57 · Evidence › Journal club · 8 Apr 2026 · 15 likes Post #54 answers the question as asked. The question underneath it is different. If you are new and reading this thread for the answer to LEADER: the answer is…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #28 · Practice › Administration · 3 Apr 2026 · 29 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #3 · Practice › Administration · 31 Mar 2026 · 1 like Bleeding at the site is common and unremarkable at these needle gauges. Persistent bruising in the same area repeatedly is worth a change of technique or of site rather…
-
Second pass at: When your prescriber and the evidence disagree Replied, post #4 · Clinical › Prescriber conversations · 25 Mar 2026 · 21 likes The failure mode on prescriber is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get wrong.
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #85 · Sourcing › Vendor reports · 24 Mar 2026 · 0 likes Photograph the vial and the label before opening. It costs ten seconds and it is what turns a report into something checkable.
-
Journal club: the CagriSema phase 2 combination paper Started this topic · Evidence › Journal club · 15 Mar 2026 · 0 likes On the subject in the title: Journal club: the CagriSema phase 2 combination paper Working notes rather than a conclusion. CagriSema phase 2 combination paper — I have…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #101 · Pharmacology › Pharmacokinetics · 8 Mar 2026 · 12 likes Speaking only to Half-life as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the…
-
Revisiting: Maintainer handover: how it works Replied, post #27 · Meta › Wiki maintenance · 3 Mar 2026 · 1 like Coming back to post #25, because the follow-up matters more than the original answer. Where I have landed on Maintainer handover, having got it wrong once in public:…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #60 · Regional › UK & Ireland · 2 Mar 2026 · 4 likes Pharmacy supply is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #74 · Practice › Storage & stability · 1 Mar 2026 · 0 likes Storing lyophilised material long term sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable…
-
Measurement error in a self-reported exposure Replied, post #6 · marked as the solution · Evidence › Study critique · 21 Feb 2026 · 25 likes Distinguishing three things in the measurement error discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation…
-
AOD-9604 and the fragment hypothesis, revisited — does this still hold? Replied, post #4 · Compounds › Other compounds · 11 Feb 2026 · 0 likes Whatever the answer on AOD-9604 turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #100 · Practice › Interactions · 29 Jan 2026 · 31 likes A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you nothing about whether it interacts. The paperwork is…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #35 · Practice › Interactions · 14 Jan 2026 · 3 likes My experience of Common supplements contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #31 · Analytics › Impurities & related substances · 1 Jan 2026 · 0 likes An honest declaration on impurities in solid-phase peptide synthesis: I have a prior here and it is strong enough that you should weight what I say downward. Stating it…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #70 · Practice › Side effects · 28 Dec 2025 · 23 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
The headache that turns out to be dehydration Replied, post #94 · Nutrition & Training › Hydration & electrolytes · 14 Dec 2025 · 8 likes A definition problem is doing most of the work in this headache discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what is left is…
-
Angle of injection and whether 90 degrees is always right Replied, post #54 · Practice › Administration · 22 Nov 2025 · 4 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. I keep…
-
What a purity-only report leaves out Replied, post #79 · Sourcing › Independent verification · 9 Nov 2025 · 14 likes If you are new and reading this thread for the answer to purity-only: the answer is conditional, the conditions are in the third reply, and the rest of the thread is…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #98 · Safety › Adverse events · 6 Nov 2025 · 9 likes Narrowing post #95, because the general version has more than one answer. The most useful contribution to this subcategory is a completed account: what happened, what…
-
EMA product information as a primary source Replied, post #36 · Regional › European Union · 6 Nov 2025 · 0 likes EMA is the regulator with national implementation. Licensed incretin analogues are prescription-only across the EU, with some variation in specific approvals by member…
-
Documentation that materially improves an appeal's chances Replied, post #52 · Access › Insurance & coverage · 5 Nov 2025 · 0 likes Summarising the documentation thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the…
-
How to read a forest plot, properly, from scratch Replied, post #50 · Evidence › Trials · 4 Nov 2025 · 0 likes Post #49 answers the question as asked. The question underneath it is different. Risk of bias: structured appraisal of internal validity. Key things to assess:…
-
A 40-week log with the measurement method stated Replied, post #81 · Outcomes › Progress reports · 27 Oct 2025 · 0 likes State the method before the numbers. Same scale, same time of day, same conditions — without that a series is a collection of readings rather than a measurement. I…
-
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #51 · Analytics › COA interpretation · 1 Oct 2025 · 0 likes Where two documents for the same lot disagree, the useful question is which was measured and which was transcribed. Most such disagreements are the second. Adding the…
-
Trust level 3 requirements: a clarification Replied, post #10 · Meta › Announcements · 30 Sep 2025 · 28 likes I would put moderate confidence on the mainstream reading of trust level 3 requirements and no more. That is not scepticism for its own sake; it is where the sourcing…
-
Freeze-thaw and why one cycle is not the same as five Replied, post #4 · Practice › Storage & stability · 22 Sep 2025 · 0 likes Understood. Thank you for being specific about the limits of it.
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #98 · Practice › Reconstitution · 2 Aug 2025 · 0 likes Concentration is total mass divided by total volume, and everything else follows from that. Ten milligrams into two millilitres is five milligrams per millilitre, and…
-
Random versus fixed effects: choosing rather than defaulting Replied, post #14 · Evidence › Meta-analyses · 30 Jun 2025 · 2 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #151 · Compounds › Cagrilintide & amylin analogues · 20 Jun 2025 · 3 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #61 · Nutrition & Training › Protein & intake · 11 Jun 2025 · 9 likes Having read the whole Tracking intake thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #54 · Compounds › Retatrutide · 22 May 2025 · 3 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
DXA precision and the least significant change for lean mass — the long version Replied, post #38 · Outcomes › Body composition · 13 May 2025 · 0 likes Post #36 is right about the mechanism and I think understates the practical bit. Where a scan disagrees with the mirror over a short period, the scan's precision limits…
-
Coming back to: Cross-border purchase rules within the EU Replied, post #4 · Regional › European Union · 2 May 2025 · 0 likes Netherlands: CBG-MEB implements framework. GPs are first point of contact. Insurance coverage for weight management is conditional on structured lifestyle programme…
-
Titles that describe the question, not the situation Started this topic · Start Here › How to Ask · 20 Apr 2025 · 43 likes Titles that describe the question, not the situation — setting out what I have, and where I think it stops being reliable. A narrow question about titles, deliberately…
-
Retatrutide dose escalation in the published trials Replied, post #137 · Compounds › Retatrutide · 15 Apr 2025 · 6 likes Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…
-
What a 2 ppm match establishes, and what it does not Replied, post #9 · Analytics › Mass spectrometry · 3 Apr 2025 · 5 likes Post #8 is the version of this I will quote in future. One addition. The reason 2 ppm match keeps being re-asked is that the answer is conditional and people quote it…
-
An orphaned page with no inbound links Replied, post #24 · Meta › Wiki maintenance · 2 Apr 2025 · 13 likes Scope creep: if a page is attempting too much, suggesting it split into multiple pages can improve clarity. Speaking for myself and not for anyone else who has posted…
-
Certificates issued by the seller versus by a laboratory Replied, post #21 · Analytics › COA interpretation · 28 Mar 2025 · 0 likes This follows post #18 rather than contradicting it. An itemised related-substances table with retention times says considerably more about the synthesis than a single…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #7 · Sourcing › Independent verification · 22 Mar 2025 · 2 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
-
Charge states for a 4 kDa peptide, worked through Replied, post #24 · Analytics › Mass spectrometry · 5 Mar 2025 · 1 like Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
-
Fibre intake when total intake falls, and the constipation link Replied, post #35 · Nutrition & Training › Protein & intake · 3 Mar 2025 · 2 likes Renal considerations around higher protein intake apply to people with existing renal impairment and are frequently generalised beyond that population. This has been…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #22 · Pharmacology › Receptor biology · 28 Feb 2025 · 0 likes I read post #20 twice before replying, because I had assumed the opposite. Receptor occupancy required for a clinical effect is not the same as full occupancy, and…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #27 · Compounds › Tirzepatide · 24 Feb 2025 · 23 likes On post #23 — agreed on the reasoning, with one qualification. Gastrointestinal effects were comparable in character to the GLP-1 monoagonists across the programme.…
-
[2026 update] Sulphur-smelling eructation: mechanism and what helps Started this topic · Practice › Side effects · 12 Feb 2025 · 10 likes Posting this under the heading it deserves: Sulphur-smelling eructation: mechanism and what helps Everything below is what sits behind that. I was wrong about…
-
Distinguishing a deletion sequence by mass alone Replied, post #69 · Analytics › Mass spectrometry · 10 Feb 2025 · 0 likes Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is wrong, and it is the commonest overclaim in this subcategory.
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #46 · Compounds › Semaglutide · 31 Jan 2025 · 18 likes Agreed on published dose-response for semaglutide, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting…
-
Second pass at: Historical amylin analogues and what happened to them Replied, post #3 · Compounds › Cagrilintide & amylin analogues · 3 Jan 2025 · 0 likes I read the opening post twice before replying, because I had assumed the opposite. Historical amylin analogues: pramlintide was the only long-acting amylin analogue…
-
What changed in 2026, by region Replied, post #44 · Access › International · 28 Dec 2024 · 14 likes Where a jurisdiction has published guidance for clinicians, that document usually answers the practical questions better than any consumer-facing page. I would put a…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #81 · Devices › Syringes & needles · 13 Dec 2024 · 0 likes Check what the graduations actually say rather than what you expect. A syringe marked in units and one marked in millilitres look similar at a glance and are not the…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #62 · Devices › Syringes & needles · 8 Nov 2024 · 18 likes The most useful thing anyone has posted about Dead volume across syringe in this category was a table of what had been measured and by whom. That is what I would want…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #84 · Clinical › Comorbidities · 23 Oct 2024 · 0 likes A condition that affects nutrition or absorption changes the calculus around a treatment that reduces intake, and that interaction is mostly unstudied.
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #99 · Access › Shortages · 12 Oct 2024 · 9 likes The published shortage register maintained by the national regulator is the authoritative source here, and it is updated far more often than any thread. That is the…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #66 · Evidence › Journal club · 7 Oct 2024 · 0 likes Everything in post #62 holds. The case it does not cover is the one I have. Practical note on SURPASS-2: write down what you expect before you look. The number of times…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #20 · Compounds › Other compounds · 27 Sep 2024 · 5 likes Adding the measurement that post #17 says would settle it. The honest summary for most of this subcategory: a plausible mechanism, animal data, and first-hand accounts.…
-
A rising related-substance total over six months: degradation or method drift? Replied, post #39 · Analytics › Impurities & related substances · 6 Sep 2024 · 11 likes I would rather this thread reach "we do not know" about rising related-substance than reach a confident answer that nobody can support when asked.
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #40 · Analytics › Mass spectrometry · 18 Aug 2024 · 0 likes Post #38 describes the usual case. This is about the unusual one. The version of High-resolution that circulates here is a simplification of a simplification. It is not…
-
Journal club: FLOW and the renal composite, component by component Replied, post #91 · Evidence › Journal club · 18 Jul 2024 · 0 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #32 · Practice › Interactions · 12 Jul 2024 · 2 likes Confirming post #30 from a second method, which matters more than confirming it from a second person. The reason oral contraceptives and delayed emptying keeps being…
-
Identical chromatograms across two different lots Replied, post #3 · Sourcing › Red flags · 3 Jul 2024 · 1 like Before the thread moves on from identical chromatograms — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an…